"Encephalopathy" trang 1 - tải miễn phí từ tailieunhanh
Sách: MISCELLANEA ON ENCEPHALOPATHIES – A SECOND LOOK

Sách: MISCELLANEA ON ENCEPHALOPATHIES – A SECOND LOOK
397    44    0
Early clinical signs in neonates with hypoxic ischemic encephalopathy predict an abnormal amplitude-integrated electroencephalogram at age 6 hours

Early clinical signs in neonates with hypoxic ischemic encephalopathy predict an abnormal amplitude-integrated electroencephalogram at age 6 hours
11    72    0
Severity of hypoxic ischemic encephalopathy and heart rate variability in neonates: A systematic review

Severity of hypoxic ischemic encephalopathy and heart rate variability in neonates: A systematic review
12    79    0
Benefits of starting hypothermia treatment within 6 h vs. 6–12 h in newborns with moderate neonatal hypoxic-ischemic encephalopathy

Benefits of starting hypothermia treatment within 6 h vs. 6–12 h in newborns with moderate neonatal hypoxic-ischemic encephalopathy
8    56    0
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)

Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)
11    64    0
Early blood glucose profile and neurodevelopmental outcome at two years in neonatal hypoxic-ischaemic encephalopathy

Early blood glucose profile and neurodevelopmental outcome at two years in neonatal hypoxic-ischaemic encephalopathy
6    61    0
A de novo SCN8A heterozygous mutation in a child with epileptic encephalopathy: A case report

A de novo SCN8A heterozygous mutation in a child with epileptic encephalopathy: A case report
6    99    0
Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: An open-label pilot study to assess the safety and feasibility

Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: An open-label pilot study to assess the safety and feasibility
6    97    0
LyTONEPAL: Long term outcome of neonatal hypoxic encephalopathy in the era of neuroprotective treatment with hypothermia: A French population-based cohort

LyTONEPAL: Long term outcome of neonatal hypoxic encephalopathy in the era of neuroprotective treatment with hypothermia: A French population-based cohort
8    80    0
Practice variation in anti-epileptic drug use for neonatal hypoxic-ischemic encephalopathy among regional NICUs

Practice variation in anti-epileptic drug use for neonatal hypoxic-ischemic encephalopathy among regional NICUs
13    68    0
Prevalence, severity and early outcomes of hypoxic ischemic encephalopathy among newborns at a tertiary hospital, in northern Tanzania

Prevalence, severity and early outcomes of hypoxic ischemic encephalopathy among newborns at a tertiary hospital, in northern Tanzania
6    99    0
Early identification of brain injury in infants with hypoxic ischemic encephalopathy at high risk for severe impairments: Accuracy of MRI performed in the first days of life

Early identification of brain injury in infants with hypoxic ischemic encephalopathy at high risk for severe impairments: Accuracy of MRI performed in the first days of life
7    72    0
Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome

Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome
3    89    0
Subcutaneous fat necrosis in neonates with hypoxic ischaemic encephalopathy registered in the Swiss National Asphyxia and Cooling Register

Subcutaneous fat necrosis in neonates with hypoxic ischaemic encephalopathy registered in the Swiss National Asphyxia and Cooling Register
7    43    0
Hepatic encephalopathy increases the risk of hip fracture: A nationwide cohort study

Hepatic encephalopathy increases the risk of hip fracture: A nationwide cohort study
6    31    1
Noninvasive mechanical ventilation with average volume assured pressure support (AVAPS) in patients with chronic obstructive pulmonary disease and hypercapnic encephalopathy

Noninvasive mechanical ventilation with average volume assured pressure support (AVAPS) in patients with chronic obstructive pulmonary disease and hypercapnic encephalopathy
7    29    1
Metronidazole-induced encephalopathy in a patient with pyogenic spondylitis: A case report

Metronidazole-induced encephalopathy in a patient with pyogenic spondylitis: A case report
5    23    1
AChE-activity in critically ill patients with suspected septic encephalopathy: A prospective, single-centre study

AChE-activity in critically ill patients with suspected septic encephalopathy: A prospective, single-centre study
10    24    1
Bovine adapted transmissible mink encephalopathy is similar to L-BSE after passage through sheep with the VRQ/VRQ genotype but not VRQ/ARQ

Bovine adapted transmissible mink encephalopathy is similar to L-BSE after passage through sheep with the VRQ/VRQ genotype but not VRQ/ARQ
14    18    1
Transcranial Doppler to assess sepsis-associated encephalopathy in critically ill patients

Transcranial Doppler to assess sepsis-associated encephalopathy in critically ill patients
6    21    1